SMAD4 and breast carcinoma: SIRT7 was found to suppress EMT in oral squamous cells, carcinoma cells, and breast cancer cells by promoting SMAD4 deacetylation, leading to increase of E-cadherin and down regulation of N-cadherin and Vimentin (26, 27).